See this page online at: http://www.biotechfocus.com/error.lasso


  • Make this your homepage
  • Print this Page


Magazine

Sign up for your free subscription and keep up-to-date.


Upcoming Events


Newsletters

Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.


Email Address

Quote of the week

“Aside from saving capital investment in facilities and equipment, hiring a CRO means that you have a whole team of experts at your disposal. An organization doing biopharmaceutical process development likely has a team of microbiologists, biochemists, and engineers working together to solve development problems.”

- As quoted in the December 2009/January 2010 issue of Biotechnology Focus.

Top Stories

Med BioGene files for US IPO
Canadian personalized diagnostics firm Med BioGene has filed for an initial public offering in the US.

Canadian CRO unveils first of its kind technology for drug development process
LAB Research Inc., a Canadian-based global non-clinical contract research organization, has completed a research and development program that involves real time quantitative pulmonary monitoring of non-human primates using wireless telemetry technology. LAB is the first ever contract laboratory to conduct such a program.

$59M supports infrastructure for 351 researchers across the country
The Canada Foundation for Innovation (CFI) has announced $59 million in support for 262 projects in 40 Canadian research institutions, allowing 351 researchers to conduct cutting-edge research in world-class facilities.

Resverlogix commences Phase 2 Atherosclerosis clinical trial
Resverlogix Corp. has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).

Spotlight

Selecting a contract research partner to help your biopharmaceutical process development
By: Amy Friesen
You've discovered a new biopharmaceutical product. You used milligrams of material for a proof-of-concept study, but now you need much more for doing additional pre-clinical work.